UMAX Group Corp (UMAX) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerUMAX Group Corp (UMAX) trades at $0.0001. UMAX Group Corp., operating as UMAX Nutrition, is a development stage company focused on natural and organic nutrition and dietary supplements. Sector: Technology.
Price as of · Last analyzed: Mar 15, 2026Analyst Coverage for UMAX: UMAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
UMAX Group Corp (UMAX) Technology Profile & Competitive Position
UMAX Group Corp., operating as UMAX Nutrition, is a development stage company in the nutritional supplement industry. It focuses on developing and distributing natural and organic nutrition products, including supplements for weight loss, sexual health, and general vitality. The company faces challenges typical of shell companies and OTC-listed entities.
What Is the Investment Thesis for UMAX?
Investing in UMAX Group Corp. presents a high-risk, high-reward scenario given its status as a development stage company operating in the competitive nutritional supplement industry. With a negative profit margin of -848.0% and a negative gross margin of -118.8%, the company's financial performance raises concerns about its ability to achieve profitability. The company's high beta of 5.85 indicates significant volatility compared to the market. Key catalysts include successful product development and market penetration, while risks include intense competition, regulatory hurdles, and the challenges inherent in operating as a shell company on the OTC market. Investors should carefully consider these factors before investing in UMAX.
Based on FMP financials and quantitative analysis
UMAX Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.15 reflects the company's current lack of profitability.
- Profit margin of -848.0% highlights significant losses and operational inefficiencies.
- Gross margin of -118.8% indicates that the cost of goods sold exceeds revenue, posing a serious challenge to the company's business model.
- Beta of 5.85 suggests high volatility compared to the overall market, making it a higher-risk investment.
Who Are UMAX's Competitors?
UMAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MNDO MIND C.T.I. Ltd. | $1.01 | +1.00% | $20.6M | — |
| IDN Intellicheck, Inc. | $2.27 | +0.22% | $46.1M | — |
| NTWK NetSol Technologies, Inc. | $6.26 | +5.21% | $74.4M | — |
| TRAK ReposiTrak, Inc. | $8.09 | -3.11% | $147M | — |
| PERF Perfect Corp. | $1.93 | +1.05% | $197M | — |
| IMMR Immersion Corporation | $7.39 | +1.09% | $245M | — |
| RMNI Rimini Street, Inc. | $4.28 | +0.83% | $399M | — |
| MTLS Materialise NV | $8.58 | +0.94% | $502M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UMAX's Key Strengths?
Focus on natural and organic ingredients.
- Specific product offerings targeting niche health needs.
- Potential for growth in the expanding nutritional supplement market.
- Established presence in the online retail channel.
What Are UMAX's Weaknesses?
Limited financial resources as a development stage company.
- Negative profit and gross margins.
- High beta indicating significant volatility.
- Dependence on a limited product line.
What Are the Key Risks for UMAX?
Financial-distress signal — its Altman Z-Score of -8.40 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from established players in the nutritional supplement industry.
- Regulatory scrutiny and compliance requirements for dietary supplements.
- Limited financial resources as a development stage company.
- Negative profit and gross margins.
- High beta indicating significant volatility.
What Are UMAX's Competitive Advantages?
- Proprietary formulations of natural and organic supplements.
- Brand recognition and customer loyalty in niche markets.
- Strategic partnerships with distributors and retailers.
- Focus on specific health needs and dietary preferences.
What Does UMAX Do?
UMAX Group Corp., founded in 2011 and based in Los Angeles, California, operates as UMAX Nutrition, focusing on the development and distribution of natural and organic nutrition and dietary supplements. As a development stage company, UMAX Nutrition aims to cater to the nutritional needs of consumers through a range of products targeting various health and wellness areas. The company's product line includes supplements designed for weight loss, colon health, sexual health, body building, and general health and vitality. UMAX Nutrition's product offerings include UPRITE XXL, a natural herbal male enhancement supplement marketed as an alternative to prescription erectile dysfunction medications. Additionally, the company offers green coffee bean extract and RASPBERRY KETONE, both known for their anti-oxidant and fat-burning properties. These products reflect the company's focus on providing natural and organic solutions to meet consumer demand in the health and wellness market. UMAX Group Corp. operates within the broader nutritional supplement industry, which is characterized by increasing consumer awareness of health and wellness, driving demand for natural and organic products. However, as a development stage company, UMAX faces challenges related to product development, marketing, distribution, and competition from established players in the industry. The company's success depends on its ability to effectively market its products, establish a strong brand presence, and navigate the regulatory landscape governing the sale of dietary supplements.
What Products and Services Does UMAX Offer?
- Develops and distributes natural and organic nutrition and dietary supplements.
- Offers products for weight loss, colon health, sexual health, body building, and general health.
- Markets UPRITE XXL, a natural herbal male enhancement supplement.
- Sells green coffee bean extract and RASPBERRY KETONE as anti-oxidant and fat-burning ingredients.
- Operates as a development stage company in the nutritional industry.
- Focuses on providing dietary needs to consumers through its product line.
How Does UMAX Make Money?
- Develops and formulates nutritional supplements.
- Markets and sells products directly to consumers and through distributors.
- Generates revenue through the sale of its nutritional supplements.
- Focuses on natural and organic ingredients to appeal to health-conscious consumers.
What Industry Does UMAX Operate In?
UMAX Group Corp. operates in the nutritional supplement industry, a segment experiencing growth driven by increasing consumer awareness of health and wellness. The market is highly competitive, with established players and numerous smaller companies vying for market share. Trends include a growing demand for natural and organic products, personalized nutrition, and online distribution channels. UMAX faces competition from companies with greater resources and established brands. The industry is also subject to regulatory scrutiny, requiring compliance with labeling and safety standards.
Who Are UMAX's Key Customers?
- Individuals seeking natural and organic nutritional supplements.
- Consumers interested in weight loss, colon health, and sexual health products.
- Health-conscious individuals looking for dietary supplements.
- Customers seeking alternatives to prescription medications for certain conditions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for UMAX Group Corp stands at 29.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -25.4%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
UMAX Group Corp operates in the Technology sector. It is headquartered in Los Angeles, US. The company is led by CEO Gerald Edick. UMAX has traded publicly since 2013.
Financial Health
UMAX Group Corp's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.40 places it in the distress zone, a signal of elevated financial risk.
UMAX Financials
UMAX Latest News
No recent news available for UMAX.
UMAX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for UMAX.
Price Targets
Wall Street price target analysis for UMAX.
UMAX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for UMAX; grades run from A+ (80-100) to F (below 30).
Leadership: Gerald Edick
CEO
Gerald Edick serves as the CEO of UMAX Group Corp. His background includes experience in the nutritional supplement industry, with a focus on product development and marketing. He has been involved in the development and launch of several nutritional supplement products. His expertise lies in identifying market trends and developing products to meet consumer demand. He is responsible for the overall strategic direction and management of the company.
Track Record: Under Gerald Edick's leadership, UMAX Group Corp. has focused on developing and distributing natural and organic nutrition and dietary supplements. Key milestones include the launch of UPRITE XXL, green coffee bean extract, and RASPBERRY KETONE. His tenure has been marked by efforts to establish a presence in the competitive nutritional supplement market, although the company continues to face financial challenges.
UMAX OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that UMAX Group Corp. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial reporting, making it difficult for investors to assess their financial health and operational performance. Unlike NYSE or NASDAQ-listed companies, OTC Other companies are not subject to stringent listing requirements, potentially increasing investment risk.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal issues.
- Monitor trading volume and price activity.
- Consult with a financial advisor before investing.
- Company has been in operation since 2011.
- Focus on developing and distributing nutritional supplements.
- Presence in the online retail channel.
- CEO with experience in the nutritional supplement industry.
What Investors Ask About UMAX Group Corp (UMAX) — Technology
What do analysts say about UMAX stock?
As of 2026-03-15, there is no available analyst coverage for UMAX Group Corp. given its OTC listing and micro-cap status.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial information available for UMAX Group Corp.
- OTC market investments carry higher risk than exchange-listed stocks.